WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
St. Pauli wins German second division title ahead of promotion to BundesligaUS troops will complete their withdrawal from Niger by midJapanese authorities urge caution after wild bears attack several people in the northeastWood scores 2 as Nottingham Forest ensures Premier League survival by beating Burnley3 dead, 3 wounded in early morning shooting in Ohio's capitalCompanies are trying to attract more smartphone users across Africa. But there are risksUS NSA, Saudi Arabia crown prince meet to discuss 'semiPacers score 39 points in first quarter vs. Knicks to set a Game 7 recordWho is Ebrahim Raisi, Iran's president involved in helicopter incidentCaicedo scores from halfway as Chelsea ends Premier League season with fifth straight win